PF4 and Miyoshi myopathy: However, human recombinant PF4 has shown proapoptotic activity by inhibiting MM cell proliferation and angiogenesis, through the inhibition of the STAT3 and IL6-STAT3 pathways, both in vitro and in vivo [78].